Secundary Prevention of Morbus Asherman

o sponsor0 个研究点目标入组 110 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•Consented patients with Asherman Syndrome (AS) who had a successful hysteroscopic adhesiolysis, defined as a restore of the normal uterine cavity, were eligible for inclusion. Patients with AS should be defined as patients with any diminishing of blood flow (secondary amenorrhoea or secondary hypomenorrhoe) after trauma to the uterine cavity due to pregnancy related surgical procedure with the presence of intrauterine adhesions with a previous history of normal menstrual blood flow.

•- Patients with a suspected AS due to tuberculosis or schitsosomiasis.
•- Patients with an uncorrected anovulation, amenorrhoe or oligomenorrhoe previous to the AS
•- Patients with suspected AS due to hysteroscopic surgery with the use of electrocoagulation (used in fibroid or polyp surgery)
•- Patients with congenital uterine anomalies
•- Patients with contraindications for a surgical adhesiolysis
•- Patients who do not master the Dutch or English language.
•- Patients who are younger than 18 years of age or mentally incompetent.
•- Patients with contraindications for estrogen and or gestagen
•-Patients who use hormonal suppletion

发起方

o sponsor